Development and Pilot Testing of Two Decision Aids for Individuals Considering Genetic Testing for Cancer Risk
暂无分享,去创建一个
Clara Gaff | Elizabeth Lobb | Judi Homewood | Michelle Peate | Kathy Tucker | J. Kirk | J. Homewood | B. Meiser | E. Lobb | C. Wakefield | K. Tucker | C. Gaff | Judy Kirk | Claire E. Wakefield | Bettina Meiser | Beverley Warner | M. Peate | B. Warner
[1] Suzanne M. Miller,et al. Enhanced Counseling for Women Undergoing BRCA1/2 Testing: Impact on Subsequent Decision Making About Risk Reduction Behaviors , 2005, Health education & behavior : the official publication of the Society for Public Health Education.
[2] G. Guanti,et al. Hereditary colorectal cancer syndromes. , 2000, Acta chirurgica Iugoslavica.
[3] J. Oosterwijk,et al. Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer , 2004, American journal of medical genetics. Part A.
[4] M. Putt,et al. Racial differences in the use of BRCA1/2 testing among women with a family history of breast or ovarian cancer. , 2005, JAMA.
[5] W. Otten,et al. What’s the message? Interpretation of an uninformative BRCA1/2 test result for women at risk of familial breast cancer , 2005, Genetics in Medicine.
[6] B. Meiser,et al. Psychological impact of genetic testing for hereditary non‐polyposis colorectal cancer , 2004, Clinical genetics.
[7] S. Narod,et al. Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy , 2004, Psycho-oncology.
[8] S. Kardia,et al. The Role of Health Education and Behavior in Public Health Genetics , 2005, Health education & behavior : the official publication of the Society for Public Health Education.
[9] B. Rimer,et al. Effects of individualized breast cancer risk counseling: a randomized trial. , 1995, Journal of the National Cancer Institute.
[10] P. Butow,et al. Tailoring communication in consultations with women from high risk breast cancer families , 2002, British Journal of Cancer.
[11] S. Domchek,et al. Knowledge, attitudes, and utilization of BRCA1/2 testing among women with early-onset breast cancer. , 2005, Genetic testing.
[12] D. Bowen,et al. Research and Practice Opportunities at the Intersection of Health Education, Health Behavior, and Genomics , 2005, Health education & behavior : the official publication of the Society for Public Health Education.
[13] Peter Tugwell,et al. Randomized Trial of a Portable, Self-administered Decision Aid for Postmenopausal Women Considering Long-term Preventive Hormone Therapy , 1998, Medical decision making : an international journal of the Society for Medical Decision Making.
[14] Susan Michie,et al. The multi-dimensional measure of informed choice: a validation study. , 2002, Patient education and counseling.
[15] G. Montgomery,et al. Family and friends with disease: their impact on perceived risk. , 2003, Preventive medicine.
[16] R. Eeles,et al. Psychosocial impact of breast/ovarian (BRCA1/2) cancer-predictive genetic testing in a UK multi-centre clinical cohort , 2004, British Journal of Cancer.
[17] S. Aymé,et al. Diffusion of information about genetic risk within families , 1993, Neuromuscular Disorders.
[18] C. Isaacs,et al. Impact of BRCA1/BRCA2 mutation testing on psychologic distress in a clinic-based sample. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[19] B. Meiser,et al. Psychological impact of genetic testing for cancer susceptibility: an update of the literature , 2005, Psycho-oncology.
[20] Suzanne M. Miller,et al. Communicating Genetic Test Results to the Family: A Six‐Step, Skills‐Building Strategy , 2001, Family & community health.
[21] Deb Feldman-Stewart,et al. Validation of a Decision Regret Scale , 2003, Medical decision making : an international journal of the Society for Medical Decision Making.
[22] Michael J Green,et al. Effect of a computer-based decision aid on knowledge, perceptions, and intentions about genetic testing for breast cancer susceptibility: a randomized controlled trial. , 2004, JAMA.
[23] W. Daal,et al. Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation , 2004, British Journal of Cancer.
[24] Suzanne M. Miller,et al. Psychological and Screening Profiles of First-Degree Relatives of Prostate Cancer Patients , 2001, Journal of Behavioral Medicine.
[25] R. Boakes,et al. Information booklets about cancer: factors influencing patient satisfaction and utilization. , 1998, Patient education and counseling.
[26] V. Entwistle,et al. Decision aids for patients facing health treatment or screening decisions: systematic review , 1999, BMJ.
[27] M. Friedlander,et al. Fertility- and menopause-related information needs of younger women with a diagnosis of early breast cancer. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] R. Croyle,et al. Genetic testing for a BRCA1 mutation: Prophylactic surgery and screening behavior in women 2 years post testing , 2003, American journal of medical genetics. Part A.
[29] P. Butow,et al. Development of a Communication Aid to Facilitate Risk Communication in Consultations with Unaffected Women from High Risk Breast Cancer Families: A Pilot Study , 2006, Journal of Genetic Counseling.
[30] I. Kirsch,et al. Colon cancer screening practices after genetic counseling and testing for hereditary nonpolyposis colorectal cancer. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[31] R. A'hern,et al. The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured interviews , 2001, BMJ : British Medical Journal.
[32] Suzanne M. Miller,et al. Decision making about prophylactic oophorectomy among at-risk women: psychological influences and implications. , 1999, Gynecologic oncology.
[33] H C van Houwelingen,et al. Risk of colorectal and endometrial cancer for carriers of mutations of the hMLH1 and hMSH2 gene: correction for ascertainment , 2005, Journal of Medical Genetics.
[34] Susan L Neuhausen,et al. Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations. , 2002, The New England journal of medicine.
[35] P. Butow,et al. How Do Geneticists and Genetic Counselors Counsel Women from High-Risk Breast Cancer Families? , 2001, Journal of Genetic Counseling.
[36] James Mackay,et al. High-risk premenopausal women's experiences of undergoing prophylactic oophorectomy: a descriptive study. , 2004, Genetic testing.
[37] I D Graham,et al. Decision aids for patients considering options affecting cancer outcomes: evidence of efficacy and policy implications. , 1999, Journal of the National Cancer Institute. Monographs.
[38] M. Friedlander,et al. The fertility‐ and menopause‐related information needs of younger women with a diagnosis of breast cancer: A qualitative study , 2003, Psycho-oncology.
[39] E. Legius,et al. Predictive testing for hereditary non-polyposis colorectal cancer: motivation, illness representations and short-term psychological impact. , 2004, Patient education and counseling.
[40] K. Glanz,et al. Correlates of intentions to obtain genetic counseling and colorectal cancer gene testing among at-risk relatives from three ethnic groups. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[41] P. Oefner,et al. Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCAmutations , 2000, British Journal of Cancer.
[42] Penny Hopwood. Psychosocial aspects of risk communication and mutation testing in familial breast-ovarian cancer , 2005, Current opinion in oncology.
[43] R. Croyle,et al. Familial context of genetic testing for cancer susceptibility: moderating effect of siblings' test results on psychological distress one to two weeks after BRCA1 mutation testing. , 1999, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.
[44] Y. Yuasa. [Hereditary nonpolyposis colorectal cancer]. , 2000, Nihon rinsho. Japanese journal of clinical medicine.
[45] Lenora E. Johnson,et al. Impact of educational print materials on knowledge, attitudes, and interest in BRCA1/BRCA2 , 2001, Cancer.
[46] J. Emery,et al. Psychological Impact of Genetic Counseling for Familial Cancer: A Systematic Review and Meta-Analysis , 2005, Familial Cancer.
[47] A. O'Connor. Validation of a Decisional Conflict Scale , 1995, Medical decision making : an international journal of the Society for Medical Decision Making.
[48] A. Cull,et al. Prophylactic oophorectomy versus screening: psychosocial outcomes in women at increased risk of ovarian cancer , 2001, Psycho-oncology.
[49] G. Colditz,et al. Colon Cancer: Risk Perceptions and Risk Communication , 2004, Journal of health communication.
[50] J. Klijn,et al. Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[51] R. Thomson,et al. Decision aids for people facing health treatment or screening decisions. , 2003, The Cochrane database of systematic reviews.
[52] G. Elwyn,et al. Decision aids for familial breast cancer: exploring women's views using focus groups , 2006, Health expectations : an international journal of public participation in health care and health policy.
[53] Linda Fleisher,et al. Facilitating Informed Decision Making about Breast Cancer Risk and Genetic Counseling Among Women Calling the NCI's Cancer Information Service , 2005, Journal of health communication.
[54] D. Evans,et al. Men in breast cancer families: a preliminary qualitative study of awareness and experience. , 1998, Journal of medical genetics.
[55] J. Klijn,et al. Psychological impact of receiving a BRCA1/BRCA2 test result. , 2001, American journal of medical genetics.
[56] M. Laya,et al. Genetic risk and breast cancer survival: another link in the chain of evidence. , 1999, Journal of the National Cancer Institute.
[57] C. Gaff,et al. Facilitating Family Communication About Predictive Genetic Testing: Probands’ Perceptions , 2005, Journal of Genetic Counseling.
[58] J. Mecklin,et al. Psychological consequences of predictive genetic testing for hereditary non‐polyposis colorectal cancer (HNPCC): A prospective follow‐up study , 2001, International journal of cancer.
[59] O. Olopade,et al. Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers. , 1999, Journal of the National Cancer Institute.
[60] J Chang-Claude,et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium. , 1998, American journal of human genetics.
[61] S. Michie,et al. The psychological consequences of offering mutation searching in the family for those at risk of hereditary breast and ovarian cancer—a pilot study , 2000, Psycho-oncology.
[62] C. Lackner,et al. Critical issues in the identification and management of patients with hereditary non-polyposis colorectal cancer , 2005, European journal of gastroenterology & hepatology.
[63] Catharine Wang,et al. A longitudinal study of psychological adjustment to familial genetic risk assessment for ovarian cancer. , 1999, Gynecologic oncology.
[64] L. Esserman,et al. Breast Cancer Risk Assessment and Prevention: A Framework for Shared Decision‐Making Consultations , 2006, The breast journal.
[65] A. Cull,et al. The impact of genetic counselling about breast cancer risk on women's risk perceptions and levels of distress , 1999, British Journal of Cancer.
[66] H. Meijers-Heijboer,et al. Long Term Follow-up of HNPCC Gene Mutation Carriers: Compliance with Screening and Satisfaction with Counseling and Screening Procedures , 2005, Familial Cancer.
[67] K. Lu,et al. Randomised trial of a decision aid and its timing for women being tested for a BRCA1/2 mutation , 2005 .
[68] J. Benkendorf,et al. Controlled trial of pretest education approaches to enhance informed decision-making for BRCA1 gene testing. , 1997, Journal of the National Cancer Institute.